LiveNowLongevityPhysician-Guided Las Vegas
702-808-2650Book Your Evaluation
Patient Questions

Is Peptide Therapy Legal in My State?

Physician-supervised peptide therapy is legal in all 51 U.S. jurisdictions below under the federal framework. What actually changes from state to state is the telehealth licensure rule — not whether peptide therapy is allowed.

Medically reviewed by Charles Kamen, MD, board-certified neurologist ·

Physician-supervised, prescription-based peptide therapy is legal in all 50 states and the District of Columbia under the federal FDA framework.Therapeutic peptides are regulated as prescription drugs under the Food, Drug & Cosmetic Act, and the vast majority are not DEA-scheduled controlled substances — so their legality tracks ordinary prescription-drug rules: a valid prescription from a licensed clinician and dispensing by a licensed pharmacy (a 503A compounding pharmacy, a 503B outsourcing facility, or an FDA-approved product). The one thing that genuinely varies by state is telehealth licensure — which clinician may evaluate a resident remotely. The table below is the honest, state-by-state answer.

Legality by state

In every jurisdiction the answer is the same — legal under the federal framework, with telehealth available. The only column that changes is the telehealth-licensure nuance.

Legality of physician-supervised peptide therapy by state — LiveNow Longevity, current as of June 18, 2026.
StateTherapy legal?Telehealth eval?Notable telehealth-licensure nuance
AlabamaLegalYesFollows the federal framework — no state-specific restriction identified.
AlaskaLegalYesNot currently an IMLC member (legislation to join was advancing in 2026 — verify current status); a treating physician must hold an Alaska license.
ArizonaLegalYesOut-of-state telehealth registration pathway available.
ArkansasLegalYesIMLC implementation still in process — verify the current pathway.
CaliforniaLegalYesNot an IMLC member (own-board license required); the Board of Pharmacy tracks FDA compounding eligibility closely and requires non-FDA-approved labeling on compounded products.
ColoradoLegalYesFollows the federal framework — no state-specific restriction identified.
ConnecticutLegalYesFollows the federal framework — no state-specific restriction identified.
DelawareLegalYesTelehealth registration pathway available.
District of ColumbiaLegalYesIMLC member jurisdiction.
FloridaLegalYesOffers a robust out-of-state telehealth registration pathway; widely regarded as a telehealth-friendly state.
GeorgiaLegalYesFollows the federal framework — no state-specific restriction identified.
HawaiiLegalYesIMLC issues-only jurisdiction (cannot be the State of Principal Licensure).
IdahoLegalYesFollows the federal framework — no state-specific restriction identified.
IllinoisLegalYesFollows the federal framework — no state-specific restriction identified.
IndianaLegalYesTelehealth registration pathway available.
IowaLegalYesFollows the federal framework — no state-specific restriction identified.
KansasLegalYesTelehealth registration pathway available.
KentuckyLegalYesFollows the federal framework — no state-specific restriction identified.
LouisianaLegalYesFollows the federal framework — no state-specific restriction identified.
MaineLegalYesTelehealth registration pathway available.
MarylandLegalYesFollows the federal framework — no state-specific restriction identified.
MassachusettsLegalYesNot an IMLC member — the treating physician must hold a Massachusetts license.
MichiganLegalYesFollows the federal framework — no state-specific restriction identified.
MinnesotaLegalYesTelehealth registration pathway available.
MississippiLegalYesFollows the federal framework — no state-specific restriction identified.
MissouriLegalYesFollows the federal framework — no state-specific restriction identified.
MontanaLegalYesFollows the federal framework — no state-specific restriction identified.
NebraskaLegalYesFollows the federal framework — no state-specific restriction identified.
NevadaLegalYesLiveNow Longevity’s home state — care is available in person in Las Vegas and by secure telehealth to Nevada residents.
New HampshireLegalYesFollows the federal framework — no state-specific restriction identified.
New JerseyLegalYesFollows the federal framework — no state-specific restriction identified.
New MexicoLegalYesIMLC implementation still in process — verify the current pathway.
New YorkLegalYesNot an IMLC member (own-board license required); the state aligns its drug rules with federal standards.
North CarolinaLegalYesJoined the IMLC, with the pathway implemented in 2026.
North DakotaLegalYesFollows the federal framework — no state-specific restriction identified.
OhioLegalYesFollows the federal framework — no state-specific restriction identified.
OklahomaLegalYesFollows the federal framework — no state-specific restriction identified.
OregonLegalYesNot an IMLC member — the treating physician must hold an Oregon license.
PennsylvaniaLegalYesFollows the federal framework — no state-specific restriction identified.
Rhode IslandLegalYesIMLC implementation still in process — verify the current pathway.
South CarolinaLegalYesNot an IMLC member — the treating physician must hold a South Carolina license.
South DakotaLegalYesFollows the federal framework — no state-specific restriction identified.
TennesseeLegalYesFollows the federal framework — no state-specific restriction identified.
TexasLegalYesIMLC member; widely regarded as a permissive state for physician-supervised, compounded peptide therapy.
UtahLegalYesFollows the federal framework — no state-specific restriction identified.
VermontLegalYesIMLC issues-only jurisdiction (cannot be the State of Principal Licensure).
VirginiaLegalYesFollows the federal framework — no state-specific restriction identified.
WashingtonLegalYesFollows the federal framework — no state-specific restriction identified.
West VirginiaLegalYesTelehealth registration pathway available.
WisconsinLegalYesFollows the federal framework — no state-specific restriction identified.
WyomingLegalYesFollows the federal framework — no state-specific restriction identified.

What “IMLC” means: the Interstate Medical Licensure Compact is an expedited multi-state physician-licensing pathway. As of mid-2026, the states that are not members are California, Massachusetts, New York, Oregon, South Carolina(Alaska was also a non-member, with legislation to join advancing in 2026) — so in those states a treating physician must obtain that state’s own license rather than use the compact. This affects which telehealth providers can serve a resident; it does not make peptide therapy illegal anywhere.

How this reference is maintained: compiled and reviewed by Charles Kamen, MDfrom primary government sources — the U.S. Food & Drug Administration’s compounding guidance, DEA drug scheduling, and state medical and pharmacy board materials. We deliberately did notadopt unverified claims of state-specific “peptide bans” that circulate on retailer blogs; several did not survive review against primary legislative sources. Regulatory status changes over time and is verified at the time of care.

This is regulatory information, not legal or medical advice. Peptide and telehealth law changes frequently and varies by individual circumstance — always confirm current status with a licensed physician, a licensed compounding pharmacy, and/or qualified legal counsel. Nothing here states that any peptide diagnoses, treats, cures, or prevents any disease, and no doses are published.

Peptide Legality FAQ

Is peptide therapy legal in all 50 states?

Yes. Physician-supervised, prescription-based peptide therapy dispensed by a licensed pharmacy is legal in all 50 states and the District of Columbia under the federal FDA framework. What differs by state is not whether peptide therapy is allowed, but the telehealth-licensure rules that govern which clinician may evaluate a resident remotely.

Are peptides a controlled substance under the DEA?

Generally no. The vast majority of therapeutic peptides are not DEA-scheduled controlled substances; they are regulated as prescription drugs under the FDA. One notable federal exception is human growth hormone, which is a federal crime to distribute without a valid prescription.

Do I need a prescription for peptide therapy?

Yes. Legitimate peptide therapy requires a prescription from a licensed clinician and dispensing by a licensed pharmacy — a 503A compounding pharmacy, a 503B outsourcing facility, or an FDA-approved product. "Research only / not for human consumption" peptides sold without a prescription are a separate, federally non-compliant category and are not legitimate clinical care.

Can I be evaluated for peptide therapy by telehealth?

In nearly every state, yes. The treating clinician simply must be licensed in the state where you are physically located during the visit — directly, through the Interstate Medical Licensure Compact (IMLC), or through a state telehealth-registration pathway. This is a licensing question, not a ban on peptide therapy.

Why do I see online claims that my state "banned" peptides?

Many such claims trace to peptide-retailer blogs and do not hold up against primary legislative sources. For example, a frequently cited "California AB 2610 peptide ban" does not exist — the real AB 2610 is an unrelated wildlife bill. Rely on FDA, DEA, and state medical and pharmacy board sources, and confirm specifics with a licensed provider.

Which states are not in the Interstate Medical Licensure Compact?

As of mid-2026, the states that are not IMLC members are California, Massachusetts, New York, Oregon, and South Carolina; Alaska was also a non-member, with legislation to join the compact advancing in 2026. In a non-member state a treating physician must obtain that state’s own license rather than use the expedited compact. Peptide therapy is legal in all of them — compact membership only affects which physicians can treat residents by telehealth.

Related reading: Is peptide therapy legal in Nevada? · Which peptides are FDA-approved? · Telehealth peptide therapy in Nevada

Physician-Led in Las Vegas

Want to know your options where you live?

A board-certified neurologist can tell you honestly what a legitimate, prescription-based peptide pathway looks like for Nevada residents — in person in Las Vegas or by secure telehealth.

Visit our clinic in Las Vegas

Ready to Start Your Longevity Journey?

Book your $88 evaluation with Dr. Kamen today — online, by phone, or by text.

Book Your $88 Evaluation

Prefer to talk? Call (702) 808-2650 or text us to book.

physician-led peptide therapy Las Vegas — visit our clinic